CERENCE CRNC 深 沪
等待开盘 12-18 09:30:00 美东时间
10.72
-0.440
-3.94%
华盛通- 最 高11.34
- 今 开11.15
- 成交量 74.67万股
- 最 低 10.67
- 昨 收 11.16
- 总市值 4.64亿
- 52周最高 27.50
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 5.94
- 委 比 -70.42%
- 总股本 4331.97万
- 历史最高 139.00
- 量 比 0.88
- 振 幅 6.00%
- 历史最低 2.34
- 每 手 1
- 风险率 2.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cerence AI Expands Beyond the Vehicle to New Areas of the Automotive Ecosystem with Launch of AI Agents
Cerence AI introduced two new conversational AI agents for automotive dealerships and OEMs at CES 2026, expanding its domain-specific solutions beyond in-vehicle experiences. The dealer assist agent automates sales and service processes, while the ownership companion agent enables proactive in-car service support, enhancing customer engagement across the automotive ecosystem.
12-11 13:00
Cerence AI to Participate in Raymond James TMT and Consumer Conference
Cerence Inc. (NASDAQ: CRNC), a global leader in conversational AI-powered user experiences, announced its participation in the Raymond James TMT and Consumer Conference on December 8, 2025, in New York City. CEO Brian Krzanich and CFO Tony Rodriquez will engage in a fireside chat at 2:20 pm ET, with a live webcast available on www.cerence.ai under the "Investors" section. A 90-day replay will follow. The company will also hold one-on-one investor...
12-01 13:00
SA Quant ranks Goldman's small-cap stocks with largest short interest
Goldman Sachs analysts last week identified 50 small-cap stocks with the highest short interest as a percentage of market cap, a list that was topped by Anavex Life Sciences (AVXL). The brokerage look...
11-27 04:13
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
11-21 15:50
Why Is PACS Group Stock On The Move Today?
Shares of PACS Group are trading higher Thursday after the healthcare company reported better-than-expected third-quarter results.
11-21 02:29
Goldman Sachs Maintains Neutral on Cerence, Raises Price Target to $11
Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $10 to $11.
11-20 21:14
Cerence Stock Skyrockets After Q4 Earnings: Here's Why
Here's a look at the Q4 earnings report from Cerence.
11-20 05:35
Cerence shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 sales guidance above estimates.
Cerence shares are trading higher after the company reported better-than-expect...
11-20 05:14
Cerence Sees Q1 Sales $110.000M-$120.000M vs $61.461M Est
Cerence (NASDAQ:CRNC) sees Q1 sales of $110.000 million-$120.000 million vs $61.461 million analyst estimate.
11-20 05:11
Cerence Q4 EPS $(0.24) Beats $(0.45) Estimate, Sales $60.639M Beat $55.259M Estimate
Cerence (NASDAQ:CRNC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.45) by 46.67 percent. This is a 242.86 percent decrease over losses of $(0.07) per share from the same
11-20 05:11
